MetLife (NYSE:MET) Price Target Lowered to $95.00 at UBS Group

MetLife (NYSE:MET) had its target price cut by stock analysts at UBS Group from $96.00 to $95.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the financial services provider’s stock. UBS Group’s price target indicates a potential upside of 25.06% from the stock’s current price.

Several other research firms also recently weighed in on MET. Cowen restated a “buy” rating on shares of MetLife in a report on Friday, August 22nd. Keefe, Bruyette & Woods cut their price target on MetLife from $94.00 to $92.00 and set an “outperform” rating for the company in a research note on Monday, August 11th. Morgan Stanley boosted their price objective on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Piper Sandler lowered MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective on the stock. in a report on Friday, September 19th. Finally, Wells Fargo & Company increased their target price on shares of MetLife from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $95.55.

MetLife Trading Down 3.5%

Shares of NYSE:MET traded down $2.72 during trading on Thursday, reaching $75.97. 3,905,672 shares of the company were exchanged, compared to its average volume of 3,361,575. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market capitalization of $50.52 billion, a PE ratio of 12.86, a P/E/G ratio of 0.70 and a beta of 0.86. The business’s fifty day simple moving average is $80.24 and its 200-day simple moving average is $78.77. MetLife has a 12-month low of $65.21 and a 12-month high of $89.05.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.34 EPS for the quarter, topping the consensus estimate of $2.30 by $0.04. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.36 billion for the quarter, compared to the consensus estimate of $18.64 billion. During the same period last year, the business posted $1.95 EPS. MetLife’s quarterly revenue was down 5.9% on a year-over-year basis. On average, research analysts anticipate that MetLife will post 9.65 EPS for the current year.

Institutional Trading of MetLife

Several institutional investors and hedge funds have recently bought and sold shares of MET. Brighton Jones LLC boosted its stake in shares of MetLife by 9.0% during the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock worth $347,000 after buying an additional 351 shares during the period. World Investment Advisors increased its holdings in shares of MetLife by 21.1% in the first quarter. World Investment Advisors now owns 7,189 shares of the financial services provider’s stock valued at $577,000 after purchasing an additional 1,251 shares during the period. U.S. Capital Wealth Advisors LLC increased its stake in MetLife by 27.2% in the 1st quarter. U.S. Capital Wealth Advisors LLC now owns 8,962 shares of the financial services provider’s stock valued at $720,000 after buying an additional 1,916 shares during the period. Stratos Investment Management LLC boosted its holdings in shares of MetLife by 9.3% in the first quarter. Stratos Investment Management LLC now owns 3,184 shares of the financial services provider’s stock valued at $256,000 after acquiring an additional 271 shares in the last quarter. Finally, Valeo Financial Advisors LLC raised its holdings in MetLife by 3.3% during the first quarter. Valeo Financial Advisors LLC now owns 10,378 shares of the financial services provider’s stock worth $833,000 after purchasing an additional 332 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.